VBIV

VBI Vaccines, Inc.

0.62 USD
+0.04 (+6.86%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

VBI Vaccines, Inc. stock is down -4.62% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 8 June’s closed higher than May.

About VBI Vaccines, Inc.

VBI Vaccines Inc. develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for chronic HBV infection.